Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Income Statement
Earnings Waterfall
Zylox-Tonbridge Medical Technology Co Ltd
Revenue
|
527.8m
CNY
|
Cost of Revenue
|
-142.8m
CNY
|
Gross Profit
|
385m
CNY
|
Operating Expenses
|
-541.5m
CNY
|
Operating Income
|
-156.5m
CNY
|
Other Expenses
|
77.8m
CNY
|
Net Income
|
-78.7m
CNY
|
Income Statement
Zylox-Tonbridge Medical Technology Co Ltd
Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|
Revenue | ||||||
Revenue |
178
N/A
|
259
+46%
|
334
+29%
|
411
+23%
|
528
+28%
|
|
Gross Profit | ||||||
Cost of Revenue |
(46)
|
(64)
|
(81)
|
(104)
|
(143)
|
|
Gross Profit |
132
N/A
|
195
+48%
|
253
+29%
|
308
+22%
|
385
+25%
|
|
Operating Income | ||||||
Operating Expenses |
(350)
|
(415)
|
(476)
|
(536)
|
(541)
|
|
Selling, General & Administrative |
(193)
|
(214)
|
(241)
|
(266)
|
(278)
|
|
Research & Development |
(162)
|
(207)
|
(223)
|
(261)
|
(261)
|
|
Depreciation & Amortization |
(9)
|
(11)
|
(19)
|
(16)
|
0
|
|
Other Operating Expenses |
14
|
17
|
8
|
7
|
(3)
|
|
Operating Income |
(218)
N/A
|
(219)
-1%
|
(223)
-2%
|
(228)
-2%
|
(157)
+31%
|
|
Pre-Tax Income | ||||||
Interest Income Expense |
18
|
64
|
119
|
114
|
78
|
|
Non-Reccuring Items |
(0)
|
(0)
|
(9)
|
(9)
|
(0)
|
|
Pre-Tax Income |
(200)
N/A
|
(155)
+22%
|
(114)
+27%
|
(123)
-9%
|
(79)
+36%
|
|
Net Income | ||||||
Tax Provision |
0
|
0
|
0
|
(0)
|
0
|
|
Income from Continuing Operations |
(200)
|
(155)
|
(114)
|
(124)
|
(79)
|
|
Net Income (Common) |
(200)
N/A
|
(155)
+22%
|
(114)
+27%
|
(124)
-9%
|
(79)
+36%
|
|
EPS (Diluted) |
-0.68
N/A
|
-0.46
+32%
|
-0.34
+26%
|
-0.37
-9%
|
-0.24
+35%
|